Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(26 sites)
United States
Mayo Clinic Comprehensive Cancer Center, Phoenix, Arizona UC Irvine Health-Chao Family Comprehensive Cancer Center, Orange, California UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California UCLA David Geffen School of Medicine, Division of Hematology/Oncology, Santa Monica, California Mayo Clinic - Jacksonville, Jacksonville, Florida